Flesh-eating Streptococcus pyogenes triggers the expression of receptor activator of nuclear factor-κB ligand

Hidenori Matsui1, Yuriko Nakatani2,3, Haruno Yoshida2

  • 1Department of Infection Control and Immunology, Kitasato Institute for Life Sciences, Kitasato University, Minato-ku, Tokyo, 108-8641, Japan. hmastui@lisci.kitasato-u.ac.jp.

Cellular Microbiology
|February 20, 2016
PubMed

Insights

Group A Streptococcus (GAS) infection in CD46 transgenic mice caused severe bone destruction. This bone loss was driven by increased receptor activator of nuclear factor-κB ligand (RANKL) produced by bone marrow cells, not T-cells.

Area of Science:

  • Immunology
  • Microbiology
  • Orthopedics

Background:

  • Human CD46 acts as a receptor for the M protein of Group A Streptococcus (GAS).
  • A specific GAS emm1 strain, GAS472, was isolated from a patient with streptococcal toxic shock-like syndrome.

Purpose of the Study:

  • To investigate the mechanism of bone destruction caused by GAS infection in a human CD46-expressing transgenic mouse model.
  • To determine the role of receptor activator of nuclear factor-κB ligand (RANKL) in GAS-induced bone loss.

Main Methods:

  • Subcutaneous infection of CD46 transgenic mice with GAS472.
  • Micro-computed tomography (Micro-CT) for bone analysis.
  • Immunohistochemistry to assess RANKL and osteoprotegerin expression.
  • Treatment with monoclonal antibodies against T-lymphocytes and RANKL.

Main Results:

  • GAS472 infection led to necrotizing fasciitis and severe, progressive bone destruction in the hind paws of CD46 Tg mice.
  • GAS infection increased RANKL expression and decreased osteoprotegerin in the hind limb bones.
  • Micro-CT revealed local bone erosion and systemic bone loss.
  • RANKL production was stimulated in various bone marrow cells, including fibroblast-like cells, and blocking RANKL inhibited osteoclast formation and bone resorption.

Conclusions:

  • GAS infection can induce significant bone destruction mediated by osteoclast activation.
  • Increased RANKL expression in heterogeneous bone marrow cells is a key factor in GAS-induced bone loss.
  • Targeting RANKL may be a therapeutic strategy for managing bone destruction during GAS infections.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.8K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
20.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
463